Literature DB >> 27490609

Sepsis in Pediatric Cardiac Intensive Care.

Derek S Wheeler1, Hector R Wong.   

Abstract

OBJECTIVES: In this review, we will discuss risk factors for developing sepsis; the role of biomarkers in establishing an early diagnosis, in monitoring therapeutic efficacy, in stratification, and for the identification of sepsis endotypes; and the pathophysiology and management of severe sepsis and septic shock, with an emphasis on the impact of sepsis on cardiovascular function. DATA SOURCE: MEDLINE and PubMed.
CONCLUSIONS: There is a lot of excitement in the field of sepsis research today. Scientific advances in the diagnosis and clinical staging of sepsis, as well as a personalized approach to the treatment of sepsis, offer tremendous promise for the future. However, at the same time, it is also evident that sepsis mortality has not improved enough, even with progress in our understanding of the molecular pathophysiology of sepsis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27490609      PMCID: PMC4975434          DOI: 10.1097/PCC.0000000000000796

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  97 in total

Review 1.  Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression.

Authors:  A Tárnok; P Schneider
Journal:  Shock       Date:  2001       Impact factor: 3.454

2.  L-type Ca2+ channel function and expression in neonatal rabbit ventricular myocytes.

Authors:  Jingbo Huang; Liqun Xu; Marion Thomas; Keith Whitaker; Leif Hove-Madsen; Glen F Tibbits
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-09       Impact factor: 4.733

Review 3.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

4.  Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock.

Authors:  Kimberly E Fenton; Craig A Sable; Michael J Bell; Kantilal M Patel; John T Berger
Journal:  Pediatr Crit Care Med       Date:  2004-11       Impact factor: 3.624

5.  Reducing catheter-associated bloodstream infections in the pediatric intensive care unit: Business case for quality improvement.

Authors:  Jeffrey E Nowak; Richard J Brilli; Michael R Lake; Karen W Sparling; John Butcher; Marion Schulte; Derek S Wheeler
Journal:  Pediatr Crit Care Med       Date:  2010-09       Impact factor: 3.624

Review 6.  Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.

Authors:  Joseph A Carcillo; Alan I Fields
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

7.  Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial.

Authors:  Reid W D Farris; Noel S Weiss; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

8.  Pediatric Sepsis - Part I: "Children are not small adults!"

Authors:  Derek S Wheeler; Hector R Wong; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

9.  Epidemiology of sepsis and multiple organ dysfunction syndrome in children.

Authors:  F Proulx; M Fayon; C A Farrell; J Lacroix; M Gauthier
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

10.  The temporal version of the pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Scott L Weiss; John S Giuliano; Mark S Wainwright; Natalie Z Cvijanovich; Neal J Thomas; Geoffrey L Allen; Nick Anas; Michael T Bigham; Mark Hall; Robert J Freishtat; Anita Sen; Keith Meyer; Paul A Checchia; Thomas P Shanley; Jeffrey Nowak; Michael Quasney; Arun Chopra; Julie C Fitzgerald; Rainer Gedeit; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.